ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Adare Acquires Egalet’s Parvulet Technology Platform
April 18, 2019Adare Pharmaceuticals has entered into an agreement with Egalet Corporation to acquire global rights of the Parvulet technology platform and its associated intellectual property (IP). -
Egalet's 70% price increase shows the buy-and-hike strategy is alive and well
February 24, 2019Think the entire pharma industry has moved past the old strategy of buying drug rights, jacking up prices and reaping the rewards? Think again. -
Egalet Announces Positive Top-Line Results from Egalet-002 Study
November 20, 2017Egalet announced positive top-line results from a phase 3 study evaluating the safety of Egalet-002, an abuse-deterrent, extended-release oxycodone developed using an application of the Guardian Technology.
Pharma Sources Insight January 2025
